ÂÜÀòÂÒÂ×

Vikram Chand, MD, possesses extensive experience in oncology and clinical development, currently serving as Vice President and Global Franchise Head for Datopotamab Deruxtecan at AstraZeneca. Previously, Vikram held several prominent positions at AstraZeneca, including Vice President of Global Product Leader and Vice President of Global Clinical Head for Immuno-Oncology in Thoracic Malignancies. Prior to AstraZeneca, Vikram served as Executive Medical Director at EMD Serono, Inc., and held multiple roles related to oncology at Boehringer Ingelheim. Vikram began the medical career as a Hematologist/Oncologist at US Oncology and a Medical Oncologist at Gundersen Lutheran. Educational qualifications include a Hematology Fellowship from the University of Iowa and an Internal Medicine Residency at Gundersen Medical Foundation.